Weichert et al.19 reported IHC-assessed expression of HDAC1, HDAC2, and HDAC3 in 38.7%, 42.7%, and 53.7% of GC tissues, respectively, in a validation cohort of patients with GC. This evidence concerns the gene HDAC1 and gastric cancer.